Latest / Diabetes Dialogue: Technology, Therapeutics, & Real-World Perspectives
Tirzepatide’s Long-Term Obesity Data
In this episode, hosts Diana Isaacs, PharmD, an endocrine clinical pharmacist, director of Education and Training in Diabetes Technology, and codirector of Endocrine Disorders in Pregnancy at the Cleveland Clinic, and Natalie Bellini, DNP, program director of Diabetes Technology at University Hospitals Diabetes and Metabolic Care Center, explore the recent updates surrounding GLP-1 receptor agonists, particularly focusing on long-term tirzepatide (Mounjaro/Zepbound) data and the current status of GLP-1 shortages.The hosts begin the episode by highlighting the FDA recently reported a…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.